Meyka AI API is live for developers.Start building.
Advertisement
Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (CGEM) Stock Overview

Explore Cullinan Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CGEM●NASDAQ
HealthcareMedical - Pharmaceuticals
$13.51
$0.92(6.38%)
U.S. Market opens in 52h 43m
Advertisement

Cullinan Therapeutics, Inc. (CGEM)

Meyka AI Score

Z

Key Financials

Market Cap830.3M
P/E Ratio-3.66
EPS (TTM)$-3.37
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 Month$15.51
3 Months$18.41
1 Year Target$3.41

CGEM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cullinan Therapeutics, Inc. (CGEM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.66 and a market capitalization of 830.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.38%
5-Day Change
-11.06%
1-Month Change
-9.57%
3-Month Change
-13.40%
6-Month Change
27.57%
Year-to-Date (YTD) Change
30.53%
1-Year Change
54.58%
3-Year Change
15.97%
5-Year Change
-60.10%
All-Time (Max) Change
-54.83%

Contact Information

https://cullinantherapeutics.com
617 410 4650
One Main Street, Cambridge, MA, 02142

Company Facts

111 Employees
IPO DateJan 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions